乳酸性酸中毒
医学
败血症
酸中毒
血小板生成素
内科学
代谢性酸中毒
中止
胃肠病学
生物
干细胞
遗传学
造血
作者
Amanda Marie Addiego,Samrah Razi,Han Li
出处
期刊:Case Reports
[BMJ]
日期:2023-12-01
卷期号:16 (12): e256463-e256463
被引量:1
标识
DOI:10.1136/bcr-2023-256463
摘要
A woman in her 60s was admitted for refractory thrombocytopenia, initially presumed to be from immune thrombocytopenia (ITP). She was treated with the thrombopoietin receptor agonist (TPO-RA) avatrombopag, as well as prophylactic ciprofloxacin and fluconazole for neutropenia. She developed an anion gap metabolic acidosis with a significantly elevated lactate level peaking at 7.5 mmol/L. Other causes of lactic acidosis including hypovolaemia, sepsis, ischaemia and diabetic ketoacidosis were ruled out. Avatrombopag was discontinued, with quick resolution of the lactic acidosis. Fluconazole and ciprofloxacin were found to inhibit the metabolism of avatrombopag and were also discontinued. Worsening thrombocytopenia prompted a rechallenge with increased dose avatrombopag and severe lactic acidosis again developed, with subsequent quick resolution after drug discontinuation. We conclude that a dose-dependent lactic acidosis occurred with avatrombopag in this case. While other TPO-RAs including eltrombopag have been associated with lactic acidosis, to our knowledge, this is the first report of avatrombopag-induced lactic acidosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI